XML 11 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Changes in Stockholders' Deficit - USD ($)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Non-controlling Interest [Member]
Beginning Balance at Dec. 31, 2023 $ (85,906,534) $ 2,042 $ 263,616,186 $ (296,096,957) $ (53,427,805)
Beginning Balance, Shares at Dec. 31, 2023   20,420,896      
Share-based compensation 1,462,748 $ 1 1,462,747    
Share-based compensation, Shares   7,277      
Cancellation of stock awards for payment of withholding tax requirements (16,398)   (16,398)    
Fair value of warrants classified as liabilities (7,754,437)   (7,754,437)    
Director compensation paid in share-based instruments 234,900   234,900    
Net income/(loss) 920,968     3,498,024 (2,577,056)
Ending Balance at Mar. 31, 2024 (91,058,753) $ 2,043 257,542,998 (292,598,933) (56,004,861)
Ending Balance, Shares at Mar. 31, 2024   20,428,173      
Beginning Balance at Dec. 31, 2023 (85,906,534) $ 2,042 263,616,186 (296,096,957) (53,427,805)
Beginning Balance, Shares at Dec. 31, 2023   20,420,896      
Net income/(loss) 6,247,129        
Ending Balance at Dec. 31, 2024 (79,083,171) $ 2,883 264,191,579 (280,439,023) (62,838,610)
Ending Balance, Shares at Dec. 31, 2024   28,825,333      
Share-based compensation 45,742   45,742    
Consultant compensation paid in stock 96,141 $ 4 96,137    
Consultant compensation paid in stock, Shares   36,500      
Director compensation paid in share-based instruments 2,700   2,700    
Common stock issued in connection with Securities Purchase Agreement, net of equity issuance costs (89,315) $ 30 (89,345)    
Common stock issued in connection with Securities Purchase Agreement, net of equity issuance costs, Shares   300,000      
Net income/(loss) (415,654)     2,241,570 (2,657,224)
Ending Balance at Mar. 31, 2025 $ (79,443,557) $ 2,917 $ 264,246,813 $ (278,197,453) $ (65,495,834)
Ending Balance, Shares at Mar. 31, 2025   29,161,833